(SMICHA) UBS (CH) – SMI (CHF) - Ratings and Ratios
Swiss Stocks, Large Cap Stocks, Equity Fund
Description: SMICHA UBS (CH) – SMI (CHF)
The UBS ETF (CH) – SMI® (CHF) A-dis is an exchange-traded fund that tracks the Morningstar Switzerland TME NR CHF Index, providing exposure to the Swiss equity market. As a Switzerland Equity ETF, it is designed to capture the performance of the Swiss market.
With Assets Under Management (AUM) of approximately CHF 2.84 billion, the fund has a substantial presence in the market. To evaluate its performance, key metrics such as tracking error, expense ratio, and dividend yield should be considered. A low tracking error would indicate that the ETF is effectively replicating the index, while a competitive expense ratio would help minimize costs for investors. The dividend yield, on the other hand, would provide insight into the income generated by the fund.
To further assess the ETFs attractiveness, investors may consider metrics such as the funds concentration ratio, sector allocation, and market capitalization distribution. A diversified portfolio with a balanced sector allocation would be more appealing to risk-averse investors. Additionally, analyzing the ETFs historical returns, Sharpe ratio, and beta would provide a more comprehensive understanding of its risk-adjusted performance.
From a trading perspective, the ETFs liquidity, average daily trading volume, and bid-ask spread are essential considerations. A liquid ETF with a narrow bid-ask spread would be more suitable for investors who require flexibility and minimal trading costs.
Additional Sources for SMICHA ETF
SMICHA ETF Overview
Market Cap in USD | 3,570m |
Category | Switzerland Equity |
IPO / Inception | 2003-12-02 |
SMICHA ETF Ratings
Growth Rating | 43.8 |
Fundamental | - |
Dividend Rating | 46.9 |
Rel. Strength | -11.8 |
Analysts | - |
Fair Price Momentum | 116.63 CHF |
Fair Price DCF | - |
SMICHA Dividends
Dividend Yield 12m | 2.71% |
Yield on Cost 5y | 3.53% |
Annual Growth 5y | 3.75% |
Payout Consistency | 95.0% |
Payout Ratio | % |
SMICHA Growth Ratios
Growth Correlation 3m | 7.9% |
Growth Correlation 12m | 40.7% |
Growth Correlation 5y | 70.9% |
CAGR 5y | 5.44% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 1.01 |
Alpha | -8.83 |
Beta | 0.533 |
Volatility | 9.49% |
Current Volume | 32.1k |
Average Volume 20d | 24.6k |
Stop Loss | 119.3 (-3%) |
As of July 16, 2025, the stock is trading at CHF 123.04 with a total of 32,138 shares traded.
Over the past week, the price has changed by -0.75%, over one month by -1.72%, over three months by +3.33% and over the past year by -0.48%.
Partly, yes. Based on ValueRay´s Analyses, UBS (CH) – SMI (CHF) (SW:SMICHA) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.77 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMICHA is around 116.63 CHF . This means that SMICHA is currently overvalued and has a potential downside of -5.21%.
UBS (CH) – SMI (CHF) has no consensus analysts rating.
According to our own proprietary Forecast Model, SMICHA UBS (CH) – SMI (CHF) will be worth about 130.2 in July 2026. The stock is currently trading at 123.04. This means that the stock has a potential upside of +5.85%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 130.2 | 5.9% |